Workflow
SSI
icon
搜索文档
Garrett Motion (GTX) - 2025 Q2 - Earnings Call Transcript
2025-07-24 21:32
Garrett Motion (GTX) Q2 2025 Earnings Call July 24, 2025 08:30 AM ET Company ParticipantsCyril Grandjean - VP - IR & TreasurerOlivier Rabiller - CEO, President & DirectorSean Deason - SVP & CFOHamed Khorsand - PrincipalJake Scholl - Equity Research AssociateEric Gregg - Founder and PrincipalOperatorHello. My name is Megan, and I will be your operator this morning. I would like to welcome everyone to the Garrett Motion Second Quarter twenty twenty five Financial Results Conference Call. This call is being re ...
Cracker Barrel's September Earnings Release Could Be Iffy, But I Expect To Remain Bullish
Seeking Alpha· 2025-07-24 21:30
After 43+ years working for one investment research company or another, I finally retired. So now, I’m completely independent. And for the first time on Seeking Alpha, I won’t be working based on anybody else’s product agenda. I have only one goal now… to give you the best actionable investment insights I can.I have long specialized in rules/factor-based equity investing strategies. But I’m different from others who share such backgrounds. I don’t serve the numbers. Instead, the numbers serve me… to inspire ...
Garrett Motion (GTX) - 2025 Q2 - Earnings Call Transcript
2025-07-24 21:30
Garrett Motion (GTX) Q2 2025 Earnings Call July 24, 2025 08:30 AM ET Speaker0Hello. My name is Megan, and I will be your operator this morning. I would like to welcome everyone to the Garrett Motion Second Quarter twenty twenty five Financial Results Conference Call. This call is being recorded and a replay will be made available later today. After the company's presentation, there will be a Q and A session.I would now like to hand the conference call over to Cyril Grandian, Garrett's Vice President, Invest ...
QUEST WATER GLOBAL ANNOUNCES STRATEGIC GOVERNMENT PARTNERSHIP
Globenewswire· 2025-07-24 21:10
VANCOUVER, CANADA, July 24, 2025 (GLOBE NEWSWIRE) -- QUEST WATER GLOBAL, INC. (OTCID: QWTR) ("Quest" and/or the "Company"), announced today that the Company has entered into a strategic partnership agreement in the Democratic Republic of Congo (“DRC”) with the National Office for Rural Hydraulics (“ONHR”), a branch of the Ministry of Rural Development (“MRD”). The agreement creates a 10-year public-private partnership between the Company and ONHR. The project governed by the agreement aims to provide afford ...
Mobileye (MBLY) - 2025 Q2 - Earnings Call Transcript
2025-07-24 21:02
财务数据和关键指标变化 - Q2营收同比增长15%,调整后运营收入增长34%,调整后运营利润率提高3个百分点至21% [6] - 运营现金流本季度超2亿美元,上半年超3亿美元,约占营收的33% [7] - 公司将全年营收预期提高4%,调整后运营收入预期提高14% [7] - 毛利率同比和环比均略有下降,运营费用同比增长7%,与Q1持平 [23][24] 各条业务线数据和关键指标变化 - 核心ADAS业务表现良好,过去四个季度的季度销量均达到或超过850万美元,IQ 6 Lite系统已在多个地区上路 [7][8][9] - 高级产品方面,公司的四个高级产品(Surround ADAS、Supervision、Chauffeur和Drive)共享通用元素,创造了协同效应 [9] - Surround ADAS系统持续发展,需求增长,有望提高每辆车的ADAS内容 [10] - Supervision业务活动依然活跃,Q2指导销量接近翻倍至40,000台 [44] - Chauffeur业务获得多个新的OEM客户,与奥迪的合作将于2027年开始量产 [40] - Robotaxi业务取得进展,已成功过渡到量产硬件,预计2025年底达到KPI目标,2026年移除司机 [17] 各个市场数据和关键指标变化 - 中国市场IQ销量在2025年有所增长,Q2调整后同比增长13%,预计稳定运行率为150万台 [66][68] - 各个市场的收入表现普遍出色,前十大客户大多有一定程度的超预期表现 [69] 公司战略和发展方向和行业竞争 - 公司是唯一的OEM中立平台,具有成本效益和可扩展性,技术路径可靠,可实现私人车辆和机器人出租车的自动驾驶 [9] - 公司通过共同的技术架构同时开发和执行四个解决方案,对市场变化保持灵活应对 [9] - 公司与多个OEM合作,包括大众、荷兰等,在运营和分销方面与大众的Moya和日本的Marubeni合作,还与Uber、Lyft等需求生成方合作 [15][16] - 在Robotaxi市场,公司认为自己在成本效益、地理扩展性和生产能力方面具有竞争优势,与大众的合作有助于在欧洲市场获得政治关注 [58][59] 管理层对经营环境和未来前景的评论 - 公司认为当前的机会比2022年上市时更大、更广泛、更深入、更紧迫,OEM的规划和决策更加清晰,短期销量强劲,对高性能和低成本的需求增加 [18] - 2027年将是收入的转折点,Supervision、Chauffeur和Robotaxi业务将开始产生收入 [46] 其他重要信息 - 公司CFO因家庭原因未参加电话会议,由首席通信官Dan Galves承担其职责 [4][5] - 公司在非GAAP指标中排除了无形资产摊销和基于股票的薪酬 [20] - 公司认为客户库存与潜在需求保持一致,预计下半年营运资金将更加现金中性 [22][25] 问答环节所有提问和回答 问题: Chauffeur业务势头增强,Supervision业务决策放缓的原因 - 欧洲和美国市场缺乏竞争压力,OEM仍处于规划阶段,不仅考虑Supervision,还关注Chauffeur和Robotaxi业务,且公司邀请OEM参观第二代Supervision系统,引起了更多兴趣 [31][33][35] 问题: Supervision是否是Chauffeur的先决条件 - 公司认为并非所有OEM都认为Supervision是Chauffeur的先决条件,一些OEM考虑直接进入Chauffeur业务,公司的产品可满足不同OEM的需求 [38][39] 问题: Supervision业务销量增长的驱动因素及2027年的影响 - 销量增长是因为Zika 9出口市场销量超预期,Polestar 4生产和需求良好,2027年将是收入的转折点,Supervision和Robotaxi业务将开始产生收入 [45][46] 问题: 英特尔减持股份的未来计划 - 公司无法评论英特尔的未来计划,但英特尔对公司潜力有信心,持有超过80%的股份 [47] 问题: Robotaxi市场的竞争情况和业务模式 - 公司认为在Robotaxi市场具有竞争优势,与大众的合作有助于在欧洲市场获得政治关注,公司通过销售系统和按里程收取费用获得收入 [58][59][60] 问题: IQ出货量增长的原因及中国市场的情况 - 增长是因为市场表现良好,中国市场IQ销量有所增长,预计稳定运行率为150万台 [66][68] 问题: DRIVE业务的资源分配和对运营费用的影响 - 公司认为运营费用在未来不会大幅增长,目前的增长已涵盖了为DRIVE、Chauffeur和Supervision业务做准备的成本 [72] 问题: 成像雷达业务的规模和未来计划 - 成像雷达业务是战略传感器,目前的交易是为了提高可信度,未来将作为EyesOff系统的一部分,不会单独销售 [77][79] 问题: 2027年Supervision、Chauffeur和Drive业务的排名 - 公司尚未准备好对2027年的业务进行指导,但Drive业务将在2026年底开始扩展到多个城市,有望推动显著增长 [80][81] 问题: 2026年Supervision业务的销量预期 - 公司认为现有车辆的出口销量将增长,美国市场的Polestar 4也将带来增长,但目前无法提供具体预期 [86][87] 问题: 库存水平与去年同期的比较 - 公司无法披露OEM的安全库存水平,但总体库存与历史时期相比处于适度水平,与需求保持一致 [90] 问题: 公司资本支出低但业务发展良好的原因 - 公司在计算资源上的支出有不同的理念,通过高效的模型训练和系统设计,实现了良好的性能 [98][99] 问题: 公司的模拟堆栈和合成数据使用情况 - 公司使用两种模拟方式,一种是用于模拟边缘情况的逼真模拟,另一种是用于训练驾驶策略的合成模拟,后者更高效 [110][111][112] 问题: Surround Data业务的获奖到项目启动的时间线 - 对于西方OEM,从提名到开始生产的时间通常为2 - 2.5年,目前大多数RFQ目标是2027 - 2028年开始生产 [116][117] 问题: 公司对Robotaxi业务车辆数量的信心来源 - 公司认为其产品在成本效益、地理扩展性和性能方面具有优势,最终将成为少数几个获得高销量的公司之一 [119][120] 问题: Drive和Robotaxi业务的商业部署地点和与合作伙伴的关系 - 司机将在2026年年中在美国的第一个城市移除,公司与大众ADMT部门紧密合作,拥有独特的远程操作员设计,可实现快速扩展 [125][126] 问题: 公司是否会考虑对合作伙伴进行战略投资 - 公司支持大众的战略投资计划,并将认真考虑参与投资 [128] 问题: 公司Compound AI平台的学习节奏和成本降低潜力 - 公司的关键绩效指标是平均故障间隔时间,目前所有指标均在按计划进行,预计到2025年底达到目标,未来可能通过减少传感器数量和升级芯片来降低成本 [131][132][134]
CenterPoint Energy(CNP) - 2025 Q2 - Earnings Call Presentation
2025-07-24 20:00
Cautionary Statement and Other Disclaimer This presentation and the oral statements made in connection herewith contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact included in this presentation and the oral statements made in connection herewith are forward-looking statements made in good faith by CenterPoint Energy, Inc. ("CenterPoint Energy" or th ...
Criteo Strengthens Product Leadership Team with Appointment of Wilfried Schobeiri
Prnewswire· 2025-07-24 20:00
As SVP, Head of Product, Performance Media, Schobeiri will help shape Criteo's future as a platform-first business and unlock greater value for brands and agenciesNEW YORK, July 24, 2025 /PRNewswire/ -- Criteo (NASDAQ: CRTO), the global platform connecting the commerce ecosystem, today announced the appointment of Wilfried Schobeiri as Senior Vice President, Head of Product, Performance Media, reporting to Chief Product Officer Todd Parsons. Schobeiri will lead Criteo's global efforts to accelerate the evol ...
Methane Emissions Intensity of Permian Basin Declined by More than Half in Two Years, New S&P Global Commodity Insights Analysis Finds
Prnewswire· 2025-07-24 19:00
New analysis provides the most accurate public, basin-wide estimate of methane emissions for the Permian HOUSTON, July 24, 2025 /PRNewswire/ -- The methane intensity of oil and gas production in the Permian Basin—an area responsible for half of U.S. oil production and one fifth of natural gas—declined by more than 50% during the 2022-2024 period as improved operations, better equipment and the utilization of AI and other advanced technologies led to reductions across all observable plume rates (large and sm ...
Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy
Globenewswire· 2025-07-24 19:00
Expedited Enrollment Surpassing 630 Targeted Participants Underscores the Strong Demand for a Therapy Focused on Vision Preservation Phase 3 ARCHER II Trial Design and Rationale to Be Presented at ASRS, a Leading Meeting for Retina Science and Innovation Topline Pivotal Phase 3 Data Expected in the Second Half of 2026 Potential for Vonaprument to Be the First Treatment Approved in Europe and the U.S. for Dry AMD with Geographic Atrophy Based on Protection of Visual Acuity and Structural Measures BRISBANE, C ...
Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy
GlobeNewswire News Room· 2025-07-24 19:00
Expedited Enrollment Surpassing 630 Targeted Participants Underscores the Strong Demand for a Therapy Focused on Vision Preservation Phase 3 ARCHER II Trial Design and Rationale to Be Presented at ASRS, a Leading Meeting for Retina Science and Innovation Topline Pivotal Phase 3 Data Expected in the Second Half of 2026 Potential for Vonaprument to Be the First Treatment Approved in Europe and the U.S. for Dry AMD with Geographic Atrophy Based on Protection of Visual Acuity and Structural Measures BRISBANE, C ...